Adage Capital Partners
TRAW icon

Adage Capital Partners’s Traws Pharma TRAW Stock Holding History

Adage Capital Partners’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Hold
730,000
– – ﹤0.01% 865
2025
Q4 		$825K Buy
730,000
+400,000
+121% +$890K ﹤0.01% 856
2025
Q3 		$611K Hold
330,000
– – ﹤0.01% 842
2025
Q2 		$488K Hold
330,000
– – ﹤0.01% 809
2025
Q1 		$759K Buy
+330,000
New +$1.72M ﹤0.01% 803

Other funds holding TRAW

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Adage Capital Partners's TRAW Position: Q1 2026 in Review

Adage Capital Partners held its Traws Pharma (TRAW) position steady in Q1 2026 at 730,000 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #865.

Adage Capital Partners first reported a position in TRAW in Q1 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Adage Capital Partners held 730,000 shares of Traws Pharma worth $1.34M as of Q1 2026.
  • Adage Capital Partners left its Traws Pharma share count unchanged in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Adage Capital Partners's portfolio in Q1 2026, its #865 holding.
  • Adage Capital Partners first reported a position in Traws Pharma in Q1 2025 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.